Clinical significance of thallium-201 SPECT after postoperative radiotherapy in patients with glioblastoma multiforme

Journal of Neuro-Oncology

Volumn 103, Issue 2, 2011, Pages 297-305

  Iida, Gyo ^a   Ogawa, Kazuhiko ^a   Ishiuchi, Shogo ^a   Chiba, Itaru ^a   Watanabe, Takashi ^a   Katsuyama, Naofumi ^b   Yoshii, Yoshihiko ^c   Murayama, Sadayuki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Department of Radiology   (Japan)

^c Tsukuba Medical Center   (Japan)

Author keywords

Glioblastoma; Prognostic factor; Radiation therapy; Thallium 201 SPECT

Indexed keywords

NIMUSTINE; PROCARBAZINE; THALLIUM 201; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DETECTION; RADIATION DOSE FRACTIONATION; RADIOACTIVITY; RECURRENT CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79959844676     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0373-8     Document Type: Article

References (40)

1. Fine HA (1994) The basis for current treatment recommendations for malignant gliomas. J Neurooncol 20:111-120
2. Laperriere N, Zuraw L, Cairncross G (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64:27-259
3. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 49:333-343 (Pubitemid 9013313)
4. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, Hatlevoll R, Lindgren M, Brun A, Lindgren S, Notter G, Andersen AP, Elgen K (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian glioblastoma study group. Cancer 47:649-665
5. Kaplan RS (1998) Complexities, pitfalls, and strategies for evaluating brain tumor therapies. Curr Opin Oncol 10:175-178
6. Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA (2000) Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217:377-384
7. Byrne TN (1994) Imaging of gliomas. Semin Oncol 21:162-171
8. Bénard F, Romsa J, Hustinx R (2003) Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 33:148-162 (Pubitemid 36577057)
9. Sun D, Liu Q, Liu W, Hu W (2000) Clinical application of201T1 SPECT imaging of brain tumor. J Nucl Med 41:5-10 (Pubitemid 30046677)
10. Ricci PE (1999) Imaging of adult brain tumors. Neuroimaging Clin N Am 9:651-669
11. Vallejos V, Balana C, Flaue M (2002) Use of201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas. J Neurooncol 59:81-90 (Pubitemid 34918716)
12. Jinnouchi S, Hoshi H, Ohnishi T, Futami S, Nagamachi S, Watanabe K, Ueda T, Wakisaka S (1993) Thallium-201 SPECT for predicting histological type of meningiomas. J Nucl Med 34:2091-2094 (Pubitemid 24002949)
13. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, Shirara N (1994) Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int J Radiat Oncol Biol Phys 30:1201-1206 (Pubitemid 24362533)
14. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D (1989) Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71:342-346 (Pubitemid 19225545)
15. Vos MJ, Hoekstra OS, Barkhof F, Berkhof J, Heimans JJ, van Groeningen CJ, Vandertop WP, Slotman BJ, Postma TJ (2003) Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma. J Clin Oncol 21:3559-3565 (Pubitemid 46594046)
16. Vertosick FT Jr, Selker RG, Grossman SJ, Joyce JM (1994) Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 34:396-401 (Pubitemid 24076983)
17. Rodrigues M, Fonseca AT, Salgado D, Vieira MR (1993) 99mTc-HMPAO brain SPECT in the evaluation of prognosis after surgical resection of astrocytoma. Comparison with other noninvasive imaging techniques (CT, MRI and201T1 SPECT). Nucl Med Commun 14:1050-1060
18. Black KL, Emerick T, Hoh C, Hawkins RA, Mazziotta J, Becker DP (1994) Thallium-201 SPECT and positron emission tomography equal predictors of glioma grde and recurrence. Neurol Res 16:93-96 (Pubitemid 24127612)
19. Bandes AA (2003) State-of-the-art treatment of high-grade brain tumors. Semin Oncol 30(suppl 19):4-9
20. Ogawa K, Yoshii Y, Inoue O, Toita T, Saito A, Kakinohana Y, Adachi G, Iraha S, Tamaki W, Sugimoto K, Hyodo A, Murayama S (2006) Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas. Br J Cancer 95:862-868 (Pubitemid 44498102)
21. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280 (Pubitemid 20195640)
22. Curren WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fishbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85:704-710 (Pubitemid 23133591)
23. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, Fischbach AJ, Curran WJ Jr (1998) Validation and predictive power of radiation therapy oncology group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40:51-55 (Pubitemid 28027566)
24. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
25. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170
26. Cox DR (1972) Regression models and life tables. J R Stat Soc 34:187-220
27. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe N, Tateno M, Tomiyoshi K, Hirano T, Inoue T, Endo K (1993) Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 34:2085-2089 (Pubitemid 24002947)
28. Higa T, Maetani S, Kobashi Y, Nabeshima S (2001) T1-201 SPECT compared with histopathologic grade in the prognostic assessment of cerebral gliomas. Clin Nucl Med 26:119-124 (Pubitemid 32102454)
29. Seiki Y, Sugo N, Kuroki T, Harada N, Yokota K, Miyazaki C, Shibata I, Tachiki K (2002) Predicting of the period of recurrent for a post-operative glioblastoma after radiochemotherapy using 201TlCl SPECT. Kaku Igaku 39:519-525 (Pubitemid 36083388)
30. Semba T, Sugawara Y, Ochi T, Fujii T, Mochizuki T, Ohnishi T (2006) Thallium-201 SPECT in prognostic assessment of malignant gliomas treated with postoperative radiotherapy. Ann Nucl Med 20:287-294 (Pubitemid 44033269)
31. Datta NR, Pasricha R, Gambhir S, Phadke RV, Prasad SN (2004) Postoperative residual tumour imaged by contrast-enhanced computed tomography and 201Tl single photon emission tomography: can they predict progression-free survival in highgrade gliomas. Clin Oncol 16:494-500 (Pubitemid 39232949)
32. Datta NR, Pasricha R, Gambhir S, Prasad SN, Phadke RV (2004) Comparative evaluation of 201Tl SPECT and CT in the follow-up of irradiated brain tumors. Int J Clin Oncol 9:51-58 (Pubitemid 38470664)
33. Kargoitis O, Rao JS, Kyritsis AP (2006) Mechanisms of angiogenesis in gliomas. J Neurooncol 78:281-293 (Pubitemid 44018823)
34. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610-622 (Pubitemid 47093931)
35. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, Takahashi M (2000) Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol 21:901-909 (Pubitemid 30262837)
36. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, Ishii Y, Kubota T (1993) Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 189:233-238 (Pubitemid 23292954)
37. Nakada K, Katoh C, Kanegae K, Tsukamoto E, Itoh K, Furudate M, Tamaki N (1996) The role of201Tl scintigraphy in evaluating proliferative activity in thyroid neoplasms. Ann Nucl Med 10:41-48
38. Suga K, Kume N, Orihashi N, Nishigauchi K, Uchisako H, Matsumoto T, Yamada N, Nakanishi T (1993) Difference in 201T1 accumulation on single photon emission computed tomography in benign and malignant thoracic lesions. Nucl Med Commun 14:1071-1078 (Pubitemid 23361283)
39. Laperriere N, Zuraw L, Cairncross G (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64:259-273 (Pubitemid 35254019)
40. Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30(suppl 19):10-14